Impact d'une invalidation de LXRα sur la physiologie prostatique : un dialogue avec la signalisation androgénique

Impact d'une invalidation de LXRα sur la physiologie prostatique : un dialogue avec la signalisation androgénique

Show other versions (1)

L’hypertrophie bénigne de la prostate (HBP) est une pathologie qui affecte 50% des hommes dès l’âge de 60 ans et qui conduit à des troubles de la miction. L’HBP se caractérise par une hypertrophie exclusive ou composite de plusieurs compartiments tissulaires de la prostate que sont l’épithélium, le...

Full description

Bibliographic Details
Main Author:	Viennois, Emilie
Other Authors:	Clermont-Ferrand 2
Language:	fr en
Published:	2011
Subjects:	Prostate Androgènes LXR Hypertrophie bénigne de la prostate SBP Androgens Benign prostatic hypertrophy
Online Access:	http://www.theses.fr/2011CLF22185/document

Similar Items

Impact d'une invalidation de LXRα sur la physiologie prostatique : un dialogue avec la signalisation androgénique
by: Viennois, Emilie
Published: (2011)

ProstaWeb: an online tool for predicting prostatic pathologies from Primary Care consultations.
by: Francisco J. Pérez-Gil, et al.
Published: (2017-04-01)

Correlation of Prostate Gland Size and Uroflowmetry in Patients with Lower Urinary Tract Symptoms
by: Deepak Sundaram, et al.
Published: (2017-05-01)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
by: Rosaria Alba Merendino, et al.
Published: (2003-01-01)

Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
by: Zhuo Li, et al.
Published: (2018-08-01)

Assesment of anogenital distance as a marker in diagnosis of prostate cancer
by: Aytac Sahin, et al.
Published: (2019-10-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Significance and clinical value of the transitional zone volume (TZV) or index (TZI) in assessing the degree of lower urinary tract obstruction: Revisited
by: M. El Ghoneimy, et al.
Published: (2017-03-01)

Is There a Relationship between Androgenic Alopecia and Benign Prostatic Hyperplasia?
by: Ladan Dastgheib, et al.
Published: (2015-01-01)

Consideration of Drug Therapy in Benign Prostatic Hypertrophy
by: G. Diamantis, et al.
Published: (2015-01-01)

Rôle du cholestérol et des récepteurs nucléaires LXRs dans le cancer de la prostate
by: Pommier, Aurélien
Published: (2010)

Rôle de la protéine nucléophosmine (NPM1/B23) dans la physiologie des tissus sensibles aux androgènes et la physiopathologie prostatique
by: Maquaire, Sabrina
Published: (2011)

Risk of Prostate Cancer after Trans Urethral Resection of BPH: A Cohort and Nested Case-Control Study
by: Beatrice Melin, et al.
Published: (2011-11-01)

Association of receptor expression with prostate volume in benign prostatic hyperplasia
by: Karli Sreenivasulu, et al.
Published: (2019-01-01)

Le blocage androgénique intermittent versus continu dans le traitement du cancer de la prostate
by: Magnan, Sindy
Published: (2015)

Bone mineral density in Nigerian men on androgen deprivation therapy for advanced prostate cancer
by: Olufemi Olayide Ojewuyi, et al.
Published: (2020-08-01)

Partial association of restriction polymorphism of the ligand binding domain of human androgen receptor in prostate cancer
by: Mohamed Hessien, et al.
Published: (2016-04-01)

Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications
by: Kai Wang, et al.
Published: (2014-04-01)

Analysis of risk factors of bladder neck contracture following transurethral surgery of prostate
by: Yi-Zhong Chen, et al.
Published: (2021-04-01)

EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality
by: Tingting Chen, et al.
Published: (2020-11-01)

EPIDEMIOLOGY OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: P I Chumakov, et al.
Published: (2018-12-01)

Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01)

Report of Frequency of Prostatic Adenocarcinoma Stage A in Patients Operated due to BPH
by: Hooshang
Published: (2003-09-01)

Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
by: Chandan Kumar Nath, et al.
Published: (2020-03-01)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2020-08-01)

Recent advances in managing chronic prostatitis/chronic pelvic pain syndrome [version 1; referees: 2 approved]
by: Jaspreet Sandhu, et al.
Published: (2017-09-01)

Distribution and structure of the pathology of the prostate gland in dogs
by: S. V. Bondar
Published: (2018-12-01)

Androgen Receptor Roles in Benign and Malignant Prostate Disease
Published: (2011-06-01)

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
by: Ramona D’Amico, et al.
Published: (2021-06-01)

Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms
by: Min Ho Lee, et al.
Published: (2021-03-01)

Rôle de l'inflammation prostatique chronique dans le développement de l'hyperplasie bénigne de la prostate
by: Robert, Grégoire
Published: (2011)

Could pollen extract in association with vitamins be favorable in the reduction of chronic prostatic inflammation? A case-series analysis
by: Michele Zazzara, et al.
Published: (2019-07-01)

Rapid versus gradual bladder decompression in acute urinary retention
by: Mohamed H Etafy, et al.
Published: (2017-01-01)

Predicting Significance of Blood Parameters in Diagnosis of Prostate Carcinoma in a Tertiary Centre in Udaipur, Rajasthan
by: Gulshan Kumar Mukhiya, et al.
Published: (2021-04-01)

Injection therapy for prostatic disease: A renaissance concept
by: Arash M Saemi, et al.
Published: (2008-01-01)

The impact of obesity towards prostate diseases
by: Dyandra Parikesit, et al.
Published: (2016-03-01)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
by: Sung Han Kim, et al.
Published: (2021-04-01)

Drugs and herbs in two divergent lines of benign prostatic hyperplasia therapy
by: Abdelkrim Berroukche, et al.
Published: (2020-04-01)

Simplified transvesical robot-assisted simple prostatectomy: Technical nuances
by: Alessandro Veccia, et al.
Published: (2020-03-01)

A Comparative Study between Cystoscopy and Cystography in Detecting Bladder Diverticulae in Patients with Benign Prostatic Hyperplasia
by: Manish Swarnkar, et al.
Published: (2016-04-01)